natgillin/translations-raw huggingface dataset:
Active substance/product-type combinations for which a decision of approval or non-approval has been adopted since 4 August 2014 are no longer in the review programme, and therefore shall no longer be referred to in part 1 of Annex II to Delegated Regulation (EU) No 1062/2014.
Kombinacije aktivnih snovi/vrst proizvodov, za katere je bil po 4. avgustu 2014 sprejet sklep o odobritvi ali neodobritvi, niso več v programu pregledovanja in zato se del 1 Priloge II k Delegirani uredbi (EU) št. 1062/2014 nanje ne bi smel več sklicevati.
The substance/product-type combinations listed in part 2 of Annex II to Delegated Regulation (EU) No 1062/2014 that were not notified pursuant to Article 14(3) of the Review Regulation should be removed from part 2 of that Annex.
Kombinacije snovi/vrst proizvodov, navedene v delu 2 Priloge II k Delegirani uredbi (EU) št. 1062/2014, ki niso bile prijavljene v skladu s členom 14(3) uredbe o pregledovanju, bi bilo treba črtati iz dela 2 navedene priloge.
Part 2 of that Annex therefore becomes obsolete and should be removed.
Del 2 navedene priloge s tem zastara in bi ga bilo treba črtati.
Consequently, part 1 of Annex II to Delegated Regulation (EU) No 1062/2014 should become Annex II as it is the only remaining part in Annex II and references to Article 14(3) and part 1 of Annex II need to be removed.
Zato bi moral del 1 Priloge II k Delegirani uredbi (EU) št. 1062/2014 postati Priloga II, saj je edini preostali del Priloge II, sklicevanja na člen 14(3) in del 1 Priloge II pa bi bilo treba črtati.
Delegated Regulation (EU) No 1062/2014 should therefore be amended accordingly,
Delegirano uredbo (EU) št. 1062/2014 bi bilo zato treba ustrezno spremeniti –
Delegated Regulation (EU) No 1062/2014 is amended as follows:
Delegirana uredba (EU) št. 1062/2014 se spremeni:
Notifications pursuant to Article 14(2) or Article 16(5) shall be made to the Agency through the Register.’
Prijave v skladu s členom 14(2) ali členom 16(5) se predložijo Agenciji prek registra.“;
in paragraph 7, point (a) is replaced by the following:
v odstavku 7 se točka (a) nadomesti z naslednjim:
where the notification has been submitted pursuant to Article 14(2), update the information in the Register with respect to the identity of the participant and, where relevant, of the substance;’.
če je bila prijava predložena v skladu s členom 14(2), posodobi informacije v registru ob upoštevanju identitete udeleženca in, kadar je ustrezno, opisa snovi;“.
In Article 20 points (b) and (c) are replaced by the following:
V členu 20 se točki (b) in (c) nadomestita z naslednjim:
where no person has submitted a notification within the time limits provided for by Article 14(2) of this Regulation, or where such a notification has been submitted and rejected pursuant to Article 17(4) or Article 17(5) thereof;
nobena oseba ni predložila prijave v rokih iz člena 14(2) te uredbe ali je bila taka prijava predložena in zavrnjena v skladu s členom 17(4) ali (5) te uredbe;
where a notification has been submitted within the time limits provided for by Article 14(2) of this Regulation and has been found compliant pursuant to Article 17(5) thereof, but the substance identity in the notification only covers part of the existing identity in Annex II to this Regulation.’.
je bila prijava predložena v rokih iz člena 14(2) te uredbe in je bilo ugotovljeno, da je skladna s členom 17(5) te uredbe, vendar opis snovi v prijavi le delno zajema obstoječi opis iz Priloge II k tej uredbi.“.
Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 (OJ L 294, 10.10.2014, p. 1).
Delegirana uredba Komisije (EU) št. 1062/2014 z dne 4. avgusta 2014 o delovnem programu za sistematično preverjanje vseh obstoječih aktivnih snovi, ki jih vsebujejo biocidni proizvodi, iz Uredbe (EU) št. 528/2012 (UL L 294, 10.10.2014, str. 1).
Commission Implementing Decision (EU) 2016/1950 of 4 November 2016 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 300, 8.11.2016, p. 14).
Izvedbeni sklep Komisije (EU) 2016/1950 z dne 4. novembra 2016 o zavrnitvi odobritve nekaterih biocidnih aktivnih snovi v skladu z Uredbo (EU) št. 528/2012 Evropskega parlamenta in Sveta (UL L 300, 8.11.2016, str. 14).
SUBSTANCE/PRODUCT-TYPE COMBINATIONS INCLUDED IN THE REVIEW PROGRAMME ON 3 FEBRUARY 2017
KOMBINACIJE SNOVI/VRST PROIZVODOV, VKLJUČENE V PROGRAM PREVERJANJA, NA DAN 3.
Active substance/product-type combinations supported on 3 February 2017 excluding any other nanomaterial than those explicitly mentioned in entries 1017, 1019 and 1023
FEBRUARJA 2017
Entry number
Kombinacije aktivnih snovi/vrst proizvodov, podprte na dan 3. februarja 2017, brez kakršnih koli nanomaterialov, ki niso bili izrecno navedeni v vnosih 1 017, 1 019 in 1 023
Substance name
Št. vnosa
Rapporteur Member State
Ime snovi
EC number
Država članica poročevalka
Formaldehyde
Številka CAS
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether (Piperonyl butoxide/PBO)
Formaldehid
Ethylene oxide
Citronska kislina
Citric acid
Glikolna kislina
Glycolic acid
Perocetna kislina
Peracetic acid
L-(+)-mlečna kislina
L-(+)-lactic acid
(2R,6aS,12aS)-1,2,6,6a,12,12a-heksahidro-2-izopropenil-8,9-dimetoksikromeno[3,4-b] furo[2,3-h]kromen-6-on (rotenon)
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one (Rotenone)
Simklozen
Biphenyl-2-ol
Cinamaldehid/3-fenil-propen-2-al (cimetov aldehid)
Cinnamaldehyde/3-phenyl-propen-2-al (Cinnamic aldehyde)
Glioksal
Glyoxal
Klorofen
Hexa-2,4-dienoic acid (Sorbic acid)
enoksietanol
Clorophene (Chlorophene)
Cetilpiridinijev klorid
henoxyethanol
Ogljikov dioksid
Cetylpyridinium chloride
Natrijev dimetilarzinat (natrijev kakodilat)
Carbon dioxide
Tozilkloramid natrij (tozilkloramid natrij – kloramin T)
Sodium dimethylarsinate (Sodium Cacodylate)
Kalijev dimetilditiokarbamat
Tosylchloramide sodium (Tosylchloramide sodium — Chloramin T)
Natrijev dimetilditiokarbamat
Potassium dimethyldithiocarbamate
Natrijev 2-bifenilat
Sodium 2-biphenylate
Metam-natrij
Thiram
iazol-4-il-1H-benzoimidazol (tiabendazol)
Metam-sodium
Cianamid
hiazol-4-yl-1H-benzoimidazole (Thiabendazole)
Tetrahidro-3,5-dimetil-1,3,5-tiadiazin-2-tion (dazomet)
Cyanamide
N-(diklorofluorometiltio)-N′,N′-dimetil-N-fenilsulfamid (diklofluanid)
Tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione (Dazomet)
(1,3,4,5,6,7-heksahidro-1,3-diokso-2H-izoindol-2-il)metil (1R-trans)-2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat (d-tetrametrin)
Terbutryn
N-(3-aminopropil)-N-dodecilpropan-1,3-diamin (diamin)
N-(Dichlorofluoromethylthio)-N′,N′-dimethyl-N-phenylsulfamide (Dichlofluanid)
2,2′-ditiobis[N-metilbenzamid] (DTBMA)
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (d-Tetramethrin)
1,2-benzizotiazol-3(2H)-on (BIT)
N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine (Diamine)
Natrijev dikloroizocianurat dihidrat
2,2′-dithiobis[N-methylbenzamide] (DTBMA)
Troklozen natrij
1,2-benzisothiazol-3(2H)-one (BIT)
Mecetronijev etil sulfat (MES)
ethyl-2H-isothiazol-3-one (MIT)
(etilendioksi)dimetanol (reakcijski produkti etilen glikola s paraformaldehidom (EGForm))
Sodium dichloroisocyanurate dihydrate
Piridin-2-tiol 1-oksid, natrijeva sol (natrijev pirition)
Troclosene sodium
Metenamin 3-kloroaliloklorid (CTAC)
Mecetronium ethyl sulphate (MES)
2,2′,2″-(heksahidro-1,3,5-triazin-1,3,5-triil)trietanol (HHT)
(ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm))
Tetrahidro-1,3,4,6-tetrakis(hidroksimetil)imidazo[4,5-d]imidazol-2,5(1H,3H)-dion (TMAD)
Pyridine-2-thiol 1-oxide, sodium salt (Sodium pyrithione)
Metilen ditiocianat
Methenamine 3-chloroallylochloride (CTAC)
1,3-bis(hidroksimetil)-5,5-dimetilimidazolidin-2,4-dion (DMDMH)
2,2′,2′-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol (HHT)
Didecildimetilamonijev klorid (DDAC)
Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione (TMAD)
Srebro
Methylene dithiocyanate
Srebro kot nanomaterial
1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH)
Žveplov dioksid
Didecyldimethylammonium chloride (DDAC)
Natrijev bromid
Silver
Natrijev hipoklorit
Sulphur dioxide
Vodikov peroksid
Sodium bromide
7a-etildihidro-1H,3H,5H-oksazolo[3,4-c]oksazol (EDHO)
Sodium hypochlorite
Srebrov nitrat
Tetramethrin
Dinatrijev peroksodisulfat/natrijev persulfat
Hydrogen peroxide
Kalcijev hipoklorit
7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO)
Klor
Silver nitrate
Amonijev sulfat
Disodium peroxodisulphate/Sodium persulphate
Srebrov klorid
Calcium hypochlorite
Piretrini in piretroidi
Chlorine
Klorov dioksid
Ammonium sulphate
2,2-dibromo-2-cianoacetamid (DBNPA)
Silver chloride
Karbendazim
Pyrethrins and Pyrethroids
Dialuminijev klorid pentahidroksid
Chlorine dioxide
Amonijev bromid
2,2-dibromo-2-cyanoacetamide (DBNPA)
Pirition cink (cinkov pirition)
Carbendazim
Dodecilgvanidin monohidroklorid
Dialuminium chloride pentahydroxide
Kalijev 2-bifenilat
Ammonium bromide
Bromov klorid
Pyrithione zinc (Zinc pyrithione)
(benziloksi)metanol
Dodecylguanidine monohydrochloride
Natrijev p-kloro-m-krezolat
Potassium 2-biphenylate
D-glukonska kislina, spojina z N,N″-bis(4-klorofenil)-3,12-diimino-2,4,11,13-tetraazatetradekandiamidin (2:1) (CHDG)
Bromine chloride
P-[(dijodometil)sulfonil]toluen
(benzyloxy)methanol
(benzotiazol-2-iltio)metil tiocianat (TCMTB)
Sodium p-chloro-m-cresolate
etil-4-okso-3-(prop-2-inil)ciklopent-2-en-1-il 2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat (praletrin)
D-gluconic acid, compound with N,N′-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1) (CHDG)
Kalijev (E,E)-heksa-2,4-dienoat (kalijev sorbat)
p-[(diiodomethyl)sulphonyl]toluene
alfa.,.alfa.′,.alfa.″-trimetil-1,3,5-triazin-1,3,5(2H,4H,6H)-trietanol (HPT)
(benzothiazol-2-ylthio)methyl thiocyanate (TCMTB)
ktil-2H-izotiazol-3-on (OIT)
ethyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin)
Dimetiloktadecil[3-(trimetoksisilil)propil]amonijev klorid
Potassium (E,E)-hexa-2,4-dienoate (Potassium Sorbate)
Bromokloro-5,5-dimetilimidazolidin-2,4-dion (BCDMH/bromoklorodimetilhidantoin)
alpha.,.alpha.′,.alpha.′-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol (HPT)
3-(4-izopropilfenil)-1,1-dimetilsečnina/izoproturon
ctyl-2H-isothiazol-3-one (OIT)
1-[2-(aliloksi)-2-(2,4-diklorofenil)etil]-1H-imidazol (imazalil)
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride
S-[(6-kloro-2-oksooksazolo[4,5-b]piridin-3(2H)-il)metil] O,O-dimetil tiofosfat (azametifos)
Bromochloro-5,5-dimethylimidazolidine-2,4-dione (BCDMH/Bromochlorodimethylhydantoin)
alfa.-ciano-3-fenoksibenzil 2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat (cifenotrin)
3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon
Dimetiltetradecil[3-(trimetoksisilil)propil]amonijev klorid
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil)
Zmes cis- in trans-p-mentan-3,8 diola (citriodiol)
S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate (Azamethiphos)
(RS)-α-ciano-3-fenoksibenzil-(1RS)-cis,trans-3-(2,2-diklorovinil)-2,2-dimetilciklopropankarboksilat (cipermetrin)
alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Cyphenothrin)
tinil-2-metilpent-2-enil 2,2-dimetil-3-(2-metilprop-1-enil)ciklopropankarboksilat (empentrin)
Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride
odo-2-propinil butilkarbamat (IPBC)
Mixture of cis- and trans-p-menthane-3,8 diol (Citriodiol)
Tetrakis(hidroksimetil)fosfonijev sulfat (2:1) (THPS)
(RS)-α-cyano-3phenoxybenzyl-(1RS)- cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin)
4,5-dikloro-2-oktilizotiazol-3(2H)-on (4,5-dikloro-2-oktil-2H-izotiazol-3-on (DCOIT))
thynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Empenthrin)
3,3′-metilenbis[5-metiloksazolidin] (oksazolidin/MBO)
odo-2-propynylbutylcarbamate (IPBC)
Alkil (C12–18) dimetilbenzil amonijev klorid (ADBAC (C12–18))
Tetrakis(hydroxymethyl)phosphonium sulphate(2:1) (THPS)
Alkil (C12–16) dimetilbenzil amonijev klorid (ADBAC/BKC (C12–16))
4,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro- 2-octyl-2H- isothiazol-3-one (DCOIT))
Didecildimetilamonijev klorid (DDAC (C8–10))
3,3′-methylenebis[5-methyloxazolidine] (Oxazolidin/MBO)
Kvaterne amonijeve spojine, benzil-C12–18-alkildimetil, soli z 1,2-benzizotiazol-3(2H)-on 1,1-dioksidom (1:1) (ADBAS)
Alkyl (C12-18) dimethylbenzyl ammonium chloride (ADBAC (C12-18))
Natrijev N-(hidroksimetil)glicinat
Alkyl (C12-16) dimethylbenzyl ammonium chloride (ADBAC/BKC (C12-C16))
Amini, C10–16-alkildimetil, N-oksidi
Didecyldimethylammonium chloride (DDAC (C8-10))
Pentakalijev bis(peroksimonosulfat) bis(sulfat)
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1) (ADBAS)
Magnezijev monoperoksiftalat heksahidrat (MMPP)
Sodium N-(hydroxymethyl)glycinate
Margoza, ekstrakt
Amines, C10-16-alkyldimethyl, N-oxides
Margoza, ekstrakt, ekstrahiran iz hladno stisnjenega olja iz jedrc Azadirachta indica s superkritičnim ogljikovim dioksidom
Pentapotassium bis(peroxymonosulphate) bis(sulphate)
Alkil (C12–14) dimetilbenzilamonijev klorid (ADBAC (C12–14))
Magnesium monoperoxyphthalate hexahydrate (MMPP)
Alkil (C12–14) dimetil(etilbenzil)amonijev klorid (ADEBAC (C12–14))
Margosa extract
Krizantema (Chrysanthemum cinerariaefolium), ekstrakt
Margosa extract from cold-pressed oil of the kernels of Azadirachta Indica extracted with super-critical carbon dioxide
Sivka (Lavandula hybrida), ekstrakt/olje sivke
Alkyl (C12-C14) dimethylbenzylammonium chloride (ADBAC (C12-C14))
Reakcijski produkti: glutaminske kisline in N-(C12–14-alkil)propilendiamin (glukoprotamin)
Alkyl (C12-C14) dimethyl(ethylbenzyl)ammonium chloride (ADEBAC (C12-C14))
6-(ftalimido)peroksiheksanojska kislina (PAP)
Chrysanthemum cinerariaefolium, ext.
util-benzo[d]izotiazol-3-on (BBIT)
Lavender, Lavandula hybrida, ext./Lavandin oil
Tetraklorodekaoksid kompleks (TCDO)
Reaction products of: glutamic acid and N-(C12-C14-alkyl)propylenediamine (Glucoprotamin)
Srebrov natrijev vodikov cirkonijev fosfat
6-(phthalimido)peroxyhexanoic acid (PAP)
Sek-butil 2-(2-hidroksietil)piperidin-1-karboksilat/ikaridin (ikaridin)
utyl-benzo[d]isothiazol-3-one (BBIT)
Cis-1-(3-kloroalil)-3,5,7-triaza-1-azoniaadamantan klorid (cis CTAC)
Tetrachlorodecaoxide complex (TCDO)
[2,4-diokso-(2-propin-1-il)imidazolidin-3-il]metil(1R)-cis-krizantemat; [2,4-diokso-(2-propin-1-il)imidazolidin-3-il]metil(1R)-trans-krizantemat (imiprotrin)
Silver sodium hydrogen zirconium phosphate
1-(2-kloro-1,3-tiazol-5-ilmetil)-3-metil-2-nitrogvanidin (klotianidin)
sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine (Icaridine)
Bacillus sphaericus razen Bacillus sphaericus 2362, sev ABTS-1743
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (cis CTAC)
mikroorganizem
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate (Imiprothrin)
Bacillus thuringiensis subsp.israelensis serotip H14 razen seva AM65-52 in razen seva SA3A
1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine (Clothianidin)
ni relevantno
Bacillus sphaericus other than Bacillus sphaericus 2362, strain ABTS-1743
Aktivni klor: pridobljen z reakcijo hipoklorne kisline in natrijevega hipoklorita in situ
Bacillus thuringiensis subsp.israelensis Serotype H14, other than strain AM65-52 and other than strain SA3A
Peroksioktanojska kislina
Not applicable
Srebrov zeolit
Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situ
Reakcijski produkti 5,5-dimetilhidantoina, 5-etil-5-metilhidantoina z bromom in klorom (DCDMH)
Mixture
ni na voljo
Peroxyoctanoic acid
Reakcijska zmes titanovega dioksida in srebrovega klorida
Silver zeolite
Reakcijski produkti 5,5-dimetilhidantoina, 5-etil-5-metilhidantoina s klorom (DCEMH)
Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with bromine and chlorine (DCDMH)
Srebrovo fosfatno steklo
Not available
Srebrov cinkov zeolit
Reaction mass of titanium dioxide and silver chloride
Srebrov bakrov zeolit
Reaction products of 5,5-dimethylhydantoin, 5-ethyl-5-methylhydantoin with chlorine (DCEMH)
Srebro, adsorbirano na silicijevem dioksidu (kot nanomaterial v obliki stabilnega agregata s primarnimi delci v nanovelikosti)
Silver phosphate glass
Silicijev dioksid (kot nanomaterial, ki ga tvorijo agregati in aglomerati)
Silver zinc zeolite
Silicijev dioksid (silicijev dioksid/kieselguhr)
Silver copper zeolite
Fitofarmacevtsko sredstvo
Silver adsorbed on silicon dioxide (as a nanomaterial in the form of a stable aggregate with primary particles in the nanoscale)
(RS)-3-alil-2-metil-4-oksociklopent-2-enil-(1R,3R;1R,3S)-2,2-dimetil-3-(2-metilprop-1-enil)-ciklopropankarboksilat (zmes 4 izomerov: 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1) (d-aletrin)
Silicon dioxide (as a nanomaterial formed by aggregates and agglomerates)
(RS)-3-alil-2-metil-4-oksociklopent-2-enil-(1R,3R)-2,2-dimetil-3-(2-metilprop-1-enil)-ciklopropankarboksilat (zmes 2 izomerov: 1R trans: 1R/S samo 1:3) (esbiotrin)
Silicium dioxide (Silicium dioxide/Kieselguhr)
N-((6-kloro-3-piridinil)metil)-N′-ciano-N-metiletanimidamid (acetamiprid)
Plant protection product
Esfenvalerat/(S)-.alfa.-ciano-3-fenoksibenzil (S)-2-(4-klorofenil)-3-metilbutirat (esfenvalerat)
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1) (d-Allethrin)
romo-2-(4-klorofenil)-1-etoksimetil-5-trifluorometilpirol-3-karbonitril (klorfenapir)
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3) (Esbiothrin)
Polimer N-metilmetanamina (EINECS 204-697-4 s (klorometil)oksiranom (EINECS 203-439-8)/polimerni kvaterni amonijev klorid (PQ polimer)
N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide (Acetamiprid)
polimer
Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyrate (Esfenvalerate)
Monohidroklorid polimera N,N″-1,6-heksandiilbis[N′-cianogvanidina] (EINECS 240-032-4) in heksametilendiamina (EINECS 204-679-6)/poliheksametilen bigvanid (monomer: 1,5-bis(trimetilen)-gvanilgvanidijev monohidroklorid) (PHMB)
romo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile (Chlorfenapyr)
Poli(heksametilenbigvanid)
Polymer of N-Methylmethanamine (Einecs 204-697-4 with (chloromethyl)oxirane (Einecs 203-439-8)/Polymeric quaternary ammonium chloride (PQ Polymer)
Poli(oksi-1,2-etandiil),.alfa.-[2-(didecilmetilamonio)etil]-.omega.-hidroksi-, propanoat (sol) (bardap 26)
Polymer
N-didecil-N-dipolietoksiamonijev borat/didecilpolioksetilamonijev borat (polimerni betain)
Commission Implementing Regulation (EU) 2017/699
Izvedbena uredba Komisije (EU) 2017/699
establishing a common methodology for the calculation of the weight of electrical and electronic equipment (EEE) placed on the market of each Member State and a common methodology for the calculation of the quantity of waste electrical and electronic equipment (WEEE) generated by weight in each Member State
o določitvi skupne metodologije za izračun teže električne in elektronske opreme (EEO), dane v promet v posamezni državi članici, in skupne metodologije za izračun količine odpadne električne in elektronske opreme (OEEO), izražene v teži, nastale v posamezni državi članici
Having regard to Directive 2012/19/EU of the European Parliament and of the Council of 4 July 2012 on waste electrical and electronic equipment (WEEE) [1], and in particular Article 7(5) thereof,
ob upoštevanju Direktive 2012/19/EU Evropskega parlamenta in Sveta z dne 4. julija 2012 o odpadni električni in elektronski opremi (OEEO) [1] ter zlasti člena 7(5) Direktive,
In order to ensure uniform conditions for the calculation of the minimum annual collection rate of WEEE by the Member States in accordance with Directive 2012/19/EU, it is necessary to establish a common methodology to be used by Member States where they calculate that collection rate based on the weight of electrical and electronic equipment (EEE) placed on their respective markets, as well as a common methodology for the calculation of the total quantity of WEEE generated by weight in each Member State, to be applied when that option becomes available to Member States in accordance with Directive 2012/19/EU.
Za zagotovitev enotnih pogojev, na podlagi katerih bodo države članice izračunale minimalno letno stopnjo zbiranja OEEO v skladu z Direktivo 2012/19/EU, je treba določiti skupno metodologijo, ki jo bodo države članice uporabljale pri izračunavanju navedene stopnje zbiranja na podlagi teže električne in elektronske opreme (EEO), dane na njihove trge, ter tudi skupno metodologijo za izračun skupne količine OEEO (izražene v teži), nastale v posamezni državi članici, ki se začne uporabljati, ko bo ta možnost na voljo državam članicam v skladu z Direktivo 2012/19/EU.
It is appropriate to define in this Regulation specific parameters, including the ‘weight of EEE’ and ‘WEEE generated’ to allow harmonised use of the common methodologies for the calculation of the weight of EEE placed on the market and for the calculation of the total quantity of WEEE generated.
Primerno je, da se v tej uredbi določijo specifični parametri, vključno s parametroma „teža EEO“ in „nastala OEEO“, da se omogoči usklajena uporaba skupnih metodologij za izračun teže EEO, dane na trg, in izračun skupne količine nastale OEEO.
To assist the application of the common methodologies for the calculation of the weight of EEE placed on the market and for the calculation of the total quantity of WEEE generated in a Member State, it is necessary that the methodologies include a calculation tool customised for each Member State.
Za podporo pri uporabi skupnih metodologij za izračun teže EEO, dane na trg, in izračun skupne količine OEEO, nastale v državi članici, je nujno, da metodologiji vključujeta orodje za izračun, prilagojeno za vsako državo članico.
Where the data to be reported by producers or their authorised representatives pursuant to Article 16 and Annex X, Part B of Directive 2012/19/EU is not available or not complete, Member States can make substantiated estimates on the quantity of EEE placed on their respective markets.
Kadar podatki, ki jih morajo sporočiti proizvajalci ali njihovi pooblaščeni zastopniki v skladu s členom 16 in delom B Priloge X k Direktivi 2012/19/EU, niso na voljo ali niso popolni, lahko države članice pripravijo utemeljene ocene količine EEO, dane na njihove trge.
In order to ensure uniform conditions for the reporting, the monitoring and the evaluation of the data, where such estimates have to be made, a common methodology should be used.
Kadar je treba pripraviti take ocene, bi bilo treba za zagotovitev enotnih pogojev za poročanje, spremljanje in ocenjevanje podatkov uporabiti skupno metodologijo.
The common methodology for calculating substantiated estimates of the quantity of EEE placed on the market should take into consideration that the quantity of EEE placed on the market in the territory of a Member State should be accounted as the weight of EEE made available on its market, excluding any EEE that have left its territory after being placed on its market.
Skupna metodologija za izračun utemeljenih ocen količine EEO, dane na trg, bi morala upoštevati, da je treba količino EEO, dane na trg na ozemlju države članice, upoštevati kot težo EEO, dostopne na njenem trgu, pri čemer se izključi vsakršna EEO, ki je zapustila njeno ozemlje po tem, ko je bila dana na njen trg.